COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms
J Loo, DA Spittle, M Newnham - Thorax, 2021 - thorax.bmj.com
Thrombotic events that frequently occur in COVID-19 are predominantly venous
thromboemboli (VTE) and are associated with increasing disease severity and worse clinical …
thromboemboli (VTE) and are associated with increasing disease severity and worse clinical …
Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland
SJ McGurnaghan, A Weir, J Bishop… - The lancet Diabetes & …, 2021 - thelancet.com
Background We aimed to ascertain the cumulative risk of fatal or critical care unit-treated
COVID-19 in people with diabetes and compare it with that of people without diabetes, and …
COVID-19 in people with diabetes and compare it with that of people without diabetes, and …
[HTML][HTML] An immune-based biomarker signature is associated with mortality in COVID-19 patients
Immune and inflammatory responses to severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) contribute to disease severity of coronavirus disease 2019 (COVID-19) …
(SARS-CoV-2) contribute to disease severity of coronavirus disease 2019 (COVID-19) …
Management of acute kidney injury in patients with COVID-19
The outbreak of coronavirus disease 2019 (COVID-19) has rapidly evolved into a global
pandemic. Most patients with COVID-19 have mild symptoms, but about 5% develop severe …
pandemic. Most patients with COVID-19 have mild symptoms, but about 5% develop severe …
Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection
LG Jacobs, E Gourna Paleoudis, D Lesky-Di Bari… - PloS one, 2020 - journals.plos.org
Background Characterizing the prevalence and persistence of symptoms associated with
COVID-19 infection following hospitalization and their impact is essential to planning post …
COVID-19 infection following hospitalization and their impact is essential to planning post …
Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry
CM Romero-Sánchez, I Díaz-Maroto… - Neurology, 2020 - AAN Enterprises
Objective The coronavirus disease 2019 (COVID-19) has spread worldwide since
December 2019. Neurologic symptoms have been reported as part of the clinical spectrum …
December 2019. Neurologic symptoms have been reported as part of the clinical spectrum …
Why COVID-19 silent hypoxemia is baffling to physicians
MJ Tobin, F Laghi, A Jubran - … journal of respiratory and critical care …, 2020 - atsjournals.org
Patients with coronavirus disease (COVID-19) are described as exhibiting oxygen levels
incompatible with life without dyspnea. The pairing—dubbed happy hypoxia but more …
incompatible with life without dyspnea. The pairing—dubbed happy hypoxia but more …
AKI in hospitalized patients with COVID-19
L Chan, K Chaudhary, A Saha… - Journal of the …, 2021 - journals.lww.com
Background Early reports indicate that AKI is common among patients with coronavirus
disease 2019 (COVID-19) and associated with worse outcomes. However, AKI among …
disease 2019 (COVID-19) and associated with worse outcomes. However, AKI among …
Respiratory follow-up of patients with COVID-19 pneumonia
The COVID-19 pandemic has led to an unprecedented surge in hospitalised patients with
viral pneumonia. The most severely affected patients are older men, individuals of black and …
viral pneumonia. The most severely affected patients are older men, individuals of black and …
REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19
DM Weinreich, S Sivapalasingam… - … England Journal of …, 2021 - Mass Medical Soc
Background Recent data suggest that complications and death from coronavirus disease
2019 (Covid-19) may be related to high viral loads. Methods In this ongoing, double-blind …
2019 (Covid-19) may be related to high viral loads. Methods In this ongoing, double-blind …